Free shipping on all orders over $ 500

Pifithrin-α, p-Nitro, Cyclic

Cat. No. M58435

All AbMole products are for research use only, cannot be used for human consumption.

Pifithrin-α, p-Nitro, Cyclic Structure
Synonym:

PFN-α

Size Price Availability Quantity
2mg USD 75  USD75 In stock
5mg USD 105  USD105 In stock
10mg USD 165  USD165 In stock
25mg USD 330  USD330 In stock
50mg USD 540  USD540 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Pifithrin-α, p-Nitro, Cyclic (PFN-α) is cell-permeable and active-form p53 inhibitor. Pifithrin-α, p-Nitro, Cyclic behaves as a p53 posttranscriptional activity inhibitor. Pifithrin-α, p-Nitro, Cyclic do not prevent p53 phosphorylation on the S15 residue. Pifithrin-α, p-Nitro, Cyclic (PFN-α) efficiently blocks p53-triggered cell death and p21/WAF1 expression in cortical neurons exposed to etoposide at concentrations one order magnitude lower than that in PFT-α.

Chemical Information
Molecular Weight 299.35
Formula C15H13N3O2S
CAS Number 60477-38-5
Form Solid
Solubility (25°C) DMF 9 mg/mL
DMSO 3 mg/mL
Storage -20°C, sealed
Related p53 Products
PK095 

PK095 is a p53 mutant stabilizer.

HLI373 

HLI373 is an efficacious Hdm2 inhibitor.

Cjoc42 

Cjoc42 is a compound capable of binding to gankyrin.

MDM2-IN-1 

MDM2-IN-1 is a synthetic MDM2-p53 interaction (MDM2) inhibitor and contains the trans (D-)configuration.

p53-MDM2-IN-4 

p53-MDM2-IN-4 is an inhibitor of p53-MDM2/X protein interaction, with a Ki value of 3.079 μM.

  Catalog
Abmole Inhibitor Catalog




Keywords: Pifithrin-α, p-Nitro, Cyclic, PFN-α supplier, p53, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.